Local toxicity with subcutaneous methadone. Experience of two centers
- 1 May 1991
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 45 (2) , 141-143
- https://doi.org/10.1016/0304-3959(91)90179-2
Abstract
We report on 8 patients treated with subcutaneous methadone for cancer-related pain at 2 institutions. The success of other subcutaneous agents for pain control has been well demonstrated. It was felt that methadone would be useful due to its low cost. Unfortunately, 7 of the 8 patients experienced adverse reactions at the subcutaneous sites requiring cessation of subcutaneous methadone.Keywords
This publication has 8 references indexed in Scilit:
- Subcutaneous infusions for control of cancer symptomsJournal of Pain and Symptom Management, 1990
- Hypodermoclysis for the Administration of Fluids and Narcotic Analgesics in Patients With Advanced CancerJNCI Journal of the National Cancer Institute, 1989
- Treatment of severe cancer pain by low-dose continuous subcutaneous morphinePain, 1989
- Use of the subcutaneous route for the administration of narcotics in patients with cancer painCancer, 1988
- Continuous Narcotic Infusion with Patient-Controlled Analgesia for Chronic Cancer Pain in OutpatientsAnnals of Internal Medicine, 1988
- Continuous subcutaneous infusion of morphine for postoperative pain reliefAnaesthesia, 1985
- CONTINUOUS SUBCUTANEOUS ANALGESICS AND ANTIEMETICS IN DOMICILIARY TERMINAL CAREThe Lancet, 1981